Maarten P. van den Berg

24.5k total citations · 2 hit papers
357 papers, 14.6k citations indexed

About

Maarten P. van den Berg is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Maarten P. van den Berg has authored 357 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 249 papers in Cardiology and Cardiovascular Medicine, 57 papers in Molecular Biology and 44 papers in Surgery. Recurrent topics in Maarten P. van den Berg's work include Cardiac electrophysiology and arrhythmias (78 papers), Atrial Fibrillation Management and Outcomes (60 papers) and Cardiomyopathy and Myosin Studies (58 papers). Maarten P. van den Berg is often cited by papers focused on Cardiac electrophysiology and arrhythmias (78 papers), Atrial Fibrillation Management and Outcomes (60 papers) and Cardiomyopathy and Myosin Studies (58 papers). Maarten P. van den Berg collaborates with scholars based in Netherlands, United States and United Kingdom. Maarten P. van den Berg's co-authors include Dirk J. van Veldhuisen, J. Peter van Tintelen, Harry J.G.M. Crijns, Arthur A.M. Wilde, Isabelle C. Van Gelder, Joost P. van Melle, Jan D.H. Jongbloed, Peter de Jonge, Johan Ormel and Jan G.P. Tijssen and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Maarten P. van den Berg

344 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis

2004 784 citations Peter de Jonge, Jan G.P. Tijssen et al. profile →
Lenient versus Strict Rate Control in Patients with Atrial Fibrillation

2010 613 citations Hessel F. Groenveld, A. Marco Alings et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maarten P. van den Berg Netherlands	67	10.2k	2.9k	1.4k	1.4k	1.3k	357	14.6k
Hiroshi Sato Japan	49	3.9k 0.4×	2.6k 0.9×	675 0.5×	1.6k 1.2×	658 0.5×	319	10.9k
Michael A. Hill United States	55	3.3k 0.3×	3.7k 1.3×	750 0.5×	1.7k 1.2×	568 0.4×	259	12.0k
Gary H. Gibbons United States	56	3.8k 0.4×	4.4k 1.5×	1.1k 0.8×	2.1k 1.6×	944 0.7×	153	11.4k
Alexandre C. Pereira Brazil	50	3.6k 0.3×	3.0k 1.0×	559 0.4×	1.8k 1.3×	1.3k 0.9×	431	10.3k
Jens Bangsbo Denmark	87	4.3k 0.4×	2.1k 0.7×	645 0.5×	932 0.7×	1.6k 1.2×	376	27.9k
Terence Dwyer Australia	74	2.6k 0.2×	1.9k 0.6×	1.1k 0.8×	1.1k 0.8×	828 0.6×	465	20.1k
Harold Snieder Netherlands	65	3.2k 0.3×	2.9k 1.0×	603 0.4×	979 0.7×	3.1k 2.3×	404	15.4k
Virginia M. Miller United States	64	3.6k 0.4×	1.9k 0.7×	1.5k 1.1×	1.7k 1.2×	2.6k 1.9×	348	13.3k
Richard Schulz Canada	59	5.1k 0.5×	4.5k 1.6×	1.2k 0.9×	1.6k 1.1×	413 0.3×	212	16.9k
José Eduardo Krieger Brazil	56	3.8k 0.4×	4.0k 1.4×	701 0.5×	2.1k 1.6×	1.4k 1.0×	517	12.2k

Countries citing papers authored by Maarten P. van den Berg

Since Specialization

Citations

This map shows the geographic impact of Maarten P. van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten P. van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten P. van den Berg more than expected).

Fields of papers citing papers by Maarten P. van den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten P. van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten P. van den Berg. The network helps show where Maarten P. van den Berg may publish in the future.

Co-authorship network of co-authors of Maarten P. van den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten P. van den Berg. A scholar is included among the top collaborators of Maarten P. van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten P. van den Berg. Maarten P. van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuijk, Sander M. J. van, et al.. (2024). Identification of Predictors for Progression of Scoliosis in Rett Syndrome. Developmental Neurorehabilitation. 27(3-4). 126–133. 1 indexed citations

Groenink, Maarten, Aeilko H. Zwinderman, Roland R.J. van Kimmenade, et al.. (2022). A cross‐sectional study on fatigue, anxiety, and symptoms of depression and their relation with medical status in adult patients with M arfan syndrome. Psychological consequences in M arfan syndrome. Clinical Genetics. 102(5). 404–413. 6 indexed citations

Vermeer, M., Maria C. Bolling, Jacqueline M. Bliley, et al.. (2021). Gain-of-function mutation in ubiquitin ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. Journal of Clinical Investigation. 131(17). 21 indexed citations

Indrakusuma, Reza, Hamid Jalalzadeh, Ron Balm, et al.. (2020). Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial. European Heart Journal. 41(43). 4181–4187. 48 indexed citations

Murray, Brittney, Edgar T. Hoorntje, Anneline S.J.M. te Riele, et al.. (2018). Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC). Journal of Cardiovascular Electrophysiology. 29(7). 1004–1009. 14 indexed citations

Walter, Daisy, Maarten P. van den Berg, Meike M. Hirdes, et al.. (2018). Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial. Endoscopy. 50(12). 1146–1155. 28 indexed citations

Hartog, Alexander W. den, Romy Franken, Maarten P. van den Berg, et al.. (2016). The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations. Netherlands Heart Journal. 24(11). 675–681. 10 indexed citations

Franken, Romy, Alexander W. den Hartog, Teodora Radonic, et al.. (2014). [Effect of losartan treatment on aortic dilatation in adults with Marfan syndrome]. University of Groningen research database (University of Groningen / Centre for Information Technology). 1 indexed citations

Groeneweg, Judith A., Paul A. van der Zwaag, Louise R.A. Olde Nordkamp, et al.. (2013). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers. The American Journal of Cardiology. 112(8). 1197–1206. 39 indexed citations

10.

Groenveld, Hessel F., Jan G.P. Tijssen, Maarten P. van den Berg, et al.. (2012). Rate control efficacy in permanent atrial fibrillation : lenient versus strict versus inadequate rate control. Data from the RACE II study. European Heart Journal. 33. 383–383. 1 indexed citations

11.

Deprez, Ronald H. Lekanne, Marjan M. Weiss, Marjon van Slegtenhorst, et al.. (2010). Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy. Netherlands Heart Journal. 18(10). 478–485. 10 indexed citations

12.

Sullivan, Benjamin D., et al.. (2010). Diagnostic Performance of Osmolarity Combined With Subset Markers of Dry Eye Disease in an Unstratified Patient Population. Investigative Ophthalmology & Visual Science. 51(13). 3380–3380. 3 indexed citations

13.

Middeldorp, Christel M., Patrick F. Sullivan, Naomi R. Wray, et al.. (2008). Suggestive linkage on chromosome 2, 8, and 17 for lifetime major depression. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(3). 352–358. 17 indexed citations

14.

Berg, Maarten P. van den & Arthur A.M. Wilde. (2008). Deteriorating consciousness and pathognomic ECG: risk of sudden death?. Netherlands Heart Journal. 16(1). 33–33. 1 indexed citations

15.

Gietema, Jourik A., Maarten P. van den Berg, Margreet Th.E. Bink‐Boelkens, et al.. (2007). Low-dose anthracyclines in childhood Acute Lymphoblastic Leukemia (ALL): no cardiac deterioration more than 20 years post-treatment. Journal of Cancer Survivorship. 1(4). 255–260. 7 indexed citations

16.

Jonge, Peter de, et al.. (2005). Prediction of depressive disorder following myocardial infarction; Data from the Myocardial Infarction and Depression - Intervention Trial (MIND-IT). Data Archiving and Networked Services (DANS). 2 indexed citations

17.

Meinardi, M.T., et al.. (2002). CORRECTION. Heart. 88(1). 82–82. 3 indexed citations

18.

Bom, Johanna G. van der, Claude Négrier, D. E. Grobbee, & Maarten P. van den Berg. (2001). Comparing prophylaxis to on demand treatment for severe hemophilia: Better outcome at equal costs.. Blood. 98(11). 1 indexed citations

19.

Berg, Maarten P. van den, et al.. (2000). Atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced heart failure. European Heart Journal. 21. 133–133. 2 indexed citations

20.

Haaksma, J., W.A. Dijk, Jorn Brouwer, et al.. (1995). COMPUTERS IN CARDIOLOGY 1995. Computing in Cardiology Conference. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact